Free Trial

AEON Biopharma (AEON) SEC Filings & 10K Form

AEON Biopharma logo
$0.71 +0.00 (+0.31%)
Closing price 04:00 PM Eastern
Extended Trading
$0.71 -0.01 (-0.74%)
As of 04:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent AEON Biopharma SEC Filings

DateFilerForm TypeView
07/09/2025
11:33 AM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Alta Partners LLC (Filed by)
Form SCHEDULE 13G/A
06/11/2025
5:04 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form DEFR14A
05/30/2025
11:10 AM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Chernett Jorey (Filed by)
Form SCHEDULE 13G
05/23/2025
3:55 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Sy Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:56 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:57 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:04 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:46 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:50 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:50 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:51 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025
3:50 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
6:21 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
Form SCHEDULE 13G/A
05/15/2025
5:35 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
S.H.N. Financial Investments Ltd. (Filed by)
Form SCHEDULE 13G/A
05/15/2025
6:07 AM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Polar Asset Management Partners Inc. (Filed by)
Form SCHEDULE 13G/A
04/29/2025
3:10 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form ARS
04/21/2025
3:11 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
3:02 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
7:45 AM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Alta Partners LLC (Filed by)
Form SCHEDULE 13G
03/10/2025
5:00 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
12:51 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Dauntless Investment Group, LLC (Filed by)
Form SCHEDULE 13G
02/24/2025
1:01 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
3:44 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Polar Asset Management Partners Inc. (Filed by)
Form SCHEDULE 13G/A
02/07/2025
3:07 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:45 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form DEF 14A
01/22/2025
3:02 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
PALMISANO ROBERT J (Filed by)
Form SCHEDULE 13D
01/13/2025
3:08 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
Form SCHEDULE 13G
01/13/2025
3:14 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
S.H.N. Financial Investments Ltd. (Filed by)
Form SCHEDULE 13G
01/13/2025
5:00 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form PRE 14A
01/08/2025
3:15 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
BIGGER CAPITAL FUND L P (Filed by)
Form SCHEDULE 13G
01/07/2025
3:05 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
5:04 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B5
01/06/2025
8:00 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
5:00 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B5
11/13/2024
3:06 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:07 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
3:08 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B3
10/07/2024
4:01 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
8:04 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
Form 4/A
09/04/2024
8:52 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:53 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Sy Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump set to Boost Social Security Checks by 400%? (Ad)

If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...

Click here to see the details because the stakes couldn't be any higher.
09/04/2024
8:58 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:58 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:58 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:59 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Forth Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:49 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:51 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
11:15 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form EFFECT
08/12/2024
3:20 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B3
08/12/2024
3:15 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 10-K/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AEON) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners